Non-caloric sweetener reduces signs of fatty liver disease in preclinical research study
Children’s Hospital Los Angeles investigator shows that non-caloric sweetener stevia decreases signs of fatty liver disease in a pre-clinical model.
Latest
- Better diet and glucose uptake in the brain lead to longer life in fruit flies
- Rapid blood test identifies COVID-19 patients at high risk of severe disease
- New study connects religiosity in US South Asians to cardiovascular disease
- USask study finds COVID isolation worsens student diets, inactivity, and alcohol intake
- Scientists offer road map to improve environmental observations in the Indian Ocean